Suppr超能文献

组织型纤溶酶原激活剂对一名患有动静脉畸形患者大脑中动脉栓子进行溶栓治疗。病例报告。

Tissue plasminogen activator thrombolysis of a middle cerebral artery embolus in a patient with an arteriovenous malformation. Case report.

作者信息

Jafar J J, Tan W S, Crowell R M

机构信息

Department of Neurosurgery, New York University Medical Center, New York.

出版信息

J Neurosurg. 1991 May;74(5):808-12. doi: 10.3171/jns.1991.74.5.0808.

Abstract

A patient harboring a cerebral arteriovenous malformation (AVM) underwent angiography in an attempt to embolize the AVM. During catheterization (and prior to embolization) he became hemiplegic and aphasic. Angiography revealed a complete middle cerebral artery (MCA) occlusion by an embolus. The patient was treated with recombinant tissue plasminogen activator (t-PA), a thrombolytic agent. Restoration of MCA flow was achieved, and the patient recovered. Immediately after MCA embolus, t-PA infusion may lead to thrombolysis and neurological recovery. The decision-making process as well as the risks associated with the use of t-PA are discussed.

摘要

一名患有脑动静脉畸形(AVM)的患者接受了血管造影,试图栓塞该AVM。在插管过程中(栓塞前),他出现了偏瘫和失语。血管造影显示大脑中动脉(MCA)被栓子完全阻塞。患者接受了重组组织型纤溶酶原激活剂(t-PA),一种溶栓药物的治疗。MCA血流得以恢复,患者康复。MCA栓子形成后立即输注t-PA可能会导致溶栓和神经功能恢复。本文讨论了决策过程以及使用t-PA相关的风险。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验